tiprankstipranks
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market
Want to see RDHL full AI Analyst Report?

RedHill Biopharma (RDHL) Financial Statements

876 Followers

RedHill Biopharma Financial Overview

RedHill Biopharma's market cap is currently $3.95M. The company's EPS TTM is $-4; its P/E ratio is -0.33; RedHill Biopharma is scheduled to report earnings on April 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 286.00K$ 8.04M$ 6.53M$ 61.80M$ 85.76M
Gross Profit$ 286.00K$ 4.85M$ 3.07M$ 28.46M$ 36.35M
Operating Income$ -7.91M$ -14.61M$ 12.63M$ -42.84M$ -81.14M
EBITDA$ -7.65M$ -7.59M$ 26.27M$ -22.18M$ -63.03M
Net Income$ -429.00K$ -8.27M$ 23.92M$ -71.67M$ -97.74M
Balance Sheet
Cash & Short-Term Investments$ 3.97M$ 4.62M$ 6.36M$ 19.98M$ 38.00M
Total Assets$ 25.34M$ 18.04M$ 23.05M$ 158.87M$ 181.19M
Total Debt$ 1.07M$ 356.00K$ 1.17M$ 122.69M$ 87.81M
Net Debt$ -2.90M$ -4.26M$ -4.40M$ 102.72M$ 58.34M
Total Liabilities$ 21.08M$ 22.73M$ 20.98M$ 207.27M$ 172.31M
Stockholders' Equity$ 4.27M$ -4.68M$ 2.07M$ -48.40M$ 8.88M
Cash Flow
Free Cash Flow$ -9.66M$ -9.38M$ -35.83M$ -29.38M$ -65.16M
Operating Cash Flow$ -9.65M$ -9.37M$ -35.82M$ -29.18M$ -65.05M
Investing Cash Flow$ 1.69M$ -9.00K$ 3.99K$ 8.30M$ -8.14M
Financing Cash Flow$ 7.32M$ 8.42M$ 21.38M$ 11.45M$ 73.46M
Currency in USD

RedHill Biopharma Earnings and Revenue History

RedHill Biopharma Debt to Assets

RedHill Biopharma Cash Flow

RedHill Biopharma Forecast EPS vs Actual EPS